Clinical trial
Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study
NCT03737435 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study
- Lead sponsor
- Istituto Ortopedico Rizzoli
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 12, 2018
- Completion date
- October 25, 2024
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
localized osteosarcoma